Tegaserod has a favorable safety & tolerability profile in patients with constipation predominant and alternating forms of irritable bowel syndrome (IBS)
- 30 April 2000
- journal article
- abstracts
- Published by Elsevier in Gastroenterology
- Vol. 118 (4) , A1204-1204
- https://doi.org/10.1016/s0016-5085(00)80649-6
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: